Overview

Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to assess whether, in GnRH agonist in vitro fertilization (IVF) cycles, where there is a risk of ovarian hyperstimulation syndrome (OHSS), the addition of cabergoline to the hydroxyethyl starch infusion could decrease OHSS incidence and severity.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Hospital de Cruces
Treatments:
Cabergoline
Hydroxyethyl Starch Derivatives
Criteria
Inclusion Criteria:

- to be at risk of OHSS were invited to participate in the study

Exclusion Criteria:

- age > 40 years